Sleep drug studied for breast cancer survivors – trial cut short
NCT ID NCT06162663
First seen Nov 01, 2025 · Last updated May 01, 2026 · Updated 23 times
Summary
This study tested whether the sleep medication suvorexant (20 mg) could help breast cancer survivors who have trouble sleeping. Five postmenopausal women who had finished cancer treatment and were taking hormone therapy were enrolled. The trial was stopped early, so results are limited.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
MUSC Department of Family Medicine
Charleston, South Carolina, 29425, United States
Conditions
Explore the condition pages connected to this study.